PET in oncology: Will it replace the other modalities?
- 30 April 1997
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 27 (2) , 94-106
- https://doi.org/10.1016/s0001-2998(97)80042-6
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- FDG-PET Evaluation of Indeterminate Pancreatic MassesJournal of Computer Assisted Tomography, 1996
- Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imagingEuropean Journal of Surgical Oncology, 1995
- Assessment of Primary and Metastatic Ovarian Cancer by Positron Emission Tomography (PET) Using 2-[18F]Deoxyglucose (2-[18F]FDG)Gynecologic Oncology, 1993
- Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-GlucoseJournal of Computer Assisted Tomography, 1993
- Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancerCancer, 1993
- Positron Emission Tomography of Thyroid MassesThyroid®, 1993
- Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studiesAmerican Journal of Roentgenology, 1988
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987
- The Solitary Pulmonary NoduleMedical Decision Making, 1985
- On the Origin of Cancer CellsScience, 1956